Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Organoheterocyclic compounds
(total 322 related compounds in database, current show from 191 to 200)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
Compound 21h
(internal name in literature)		 Depiction based on curated SMILES N O HO Cl F Cl H H Cl N H O Mycobacterium Exoenzyme Preclinical (in vitro) Nören-Müller A, et al. 2006. Proc Natl Acad Sci U S A
Compound 21i
(internal name in literature)		 Depiction based on curated SMILES N O HO F Cl H H Cl N H O Mycobacterium Exoenzyme Preclinical (in vitro) Nören-Müller A, et al. 2006. Proc Natl Acad Sci U S A
Compound 21j
(internal name in literature)		 Depiction based on curated SMILES N S O O + N O _ O Br Cl H H N H O OH Mycobacterium Exoenzyme Preclinical (in vitro) Nören-Müller A, et al. 2006. Proc Natl Acad Sci U S A
Compound 19c
(internal name in literature)		 Depiction based on curated SMILES N H HO O H H N Cl Cl Mycobacterium Exoenzyme Preclinical (in vitro) Nören-Müller A, et al. 2006. Proc Natl Acad Sci U S A
(2Z)-2-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-7,8-dimethyl[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-one Depiction based on curated SMILES H 3 C OH Cl O N H 3 C CH 3 N S O Pseudomonas
Yersinia		 TTSS (Type III secretion system)
TTSS (Type III secretion system)		 Preclinical (in vitro)
Preclinical (in vitro)		 Harmon DE, et al. 2010. Antimicrob Agents Chemother
5beta,6alpha-Bis(4-cyclopropyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine Depiction based on curated SMILES H 2 N N H N N N N H H N N N Pseudomonas Biofilm Preclinical (in vitro) Huigens RW 3rd, et al. 2009. Org Biomol Chem
(E)-3-(4-Acetyl-phenyl)-N-[4-(1-hydroxy-6-nitro-1H-benzoimidazol-2-yl)-phenyl]-acrylamide Depiction based on curated SMILES N + N O _ O N HO H 3 C N H O O Pseudomonas TTSS (Type III secretion system) Preclinical (in vitro) Marsden AE, et al. 2016. Antimicrob Agents Chemother
(E)-3-(4-acetylphenyl)-N-(4-(6-cyano-1-hydroxy-1H-benzo[d]imidazol-2-yl)phenyl)acrylamide Depiction based on curated SMILES HO N N N H 3 C N H O O Pseudomonas TTSS (Type III secretion system) Preclinical (in vitro) Marsden AE, et al. 2016. Antimicrob Agents Chemother
(E)-3-(4-fluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide Depiction based on curated SMILES HO N _ O O + N N O N H F Pseudomonas
Yersinia
Yersinia		 TTSS (Type III secretion system)
TTSS (Type III secretion system)
TTSS (Type III secretion system)		 Preclinical (in vitro)
Preclinical (in vitro)
Preclinical (in vivo)		 Marsden AE, et al. 2016. Antimicrob Agents Chemother
Kim OK, et al. 2009. J Med Chem
Garrity-Ryan LK, et al. 2010. Infect Immun
1-{(E)-[(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)imino]methyl}naphthalen-2-ol Depiction based on curated SMILES N OH H 3 C CH 3 N N Pseudomonas
Yersinia		 TTSS (Type III secretion system)
TTSS (Type III secretion system)		 Preclinical (in vitro)
Preclinical (in vitro)		 Harmon DE, et al. 2010. Antimicrob Agents Chemother
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page 1  ...  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  ...  33



Back to top
2004-2024 NIPB, CAMS&PUMC